Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis

BACKGROUND: In lymphangioleiomyomatosis (LAM), tuberous sclerosis gene mutations activate the mechanistic target of the rapamycin pathway, resulting in vascular endothelial growth factor-D (VEGF-D) overproduction. While the utility of serum VEGF-D testing for the diagnosis of LAM is outlined in ATS/...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Masaki, Matsumuro, Akiko, Arai, Toru, Sugimoto, Chikatoshi, Akira, Masanori, Kitaichi, Masanori, Young, Lisa R., McCormack, Francis X., Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395035/
https://www.ncbi.nlm.nih.gov/pubmed/30818375
http://dx.doi.org/10.1371/journal.pone.0212776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395035/
https://www.ncbi.nlm.nih.gov/pubmed/30818375
http://dx.doi.org/10.1371/journal.pone.0212776

Ejemplares similares